# Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells

> **NCT05167552** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus** · enrollment: 60 (estimated)

## Conditions studied

- Allergic Rhinitis
- Rhinosinusitis Chronic

## Interventions

- **BIOLOGICAL:** Olfactory mucosa-derived mesenchymal stem cells
- **OTHER:** Standard treatment of type Allergic Rhinitis according to the clinical protocols
- **OTHER:** Standard treatment of type Chronic Polypous Rhinosinusitis according to the clinical protocols

## Key facts

- **NCT ID:** NCT05167552
- **Lead sponsor:** Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05167552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05167552, "Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05167552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*